Diphosphonate solutions
OwnerGregory Paul Handreck, Wei Zhou +1inventors
InventorsGregory Paul Handreck, Wei Zhou, Russell John Tait
Life of this patent
Estimating the term…
Abstract
A pharmaceutical product containing pamidronate and other diphosphonate solutions in an appropriate container, a pH of between 5 and 8 and without organic acid buffer or polyethylen glycol. The container may be treated glass or made of other appropriate material. Coated elastomeric stoppers are also included. A method of producing a pharmaceutical product comprising steps of making a suspension of pamadronic acid, adding sodium hydroxide, to form a solution adjusting the pH to between 5 and 8 and transferring the solution to a container.
Claims27
A pharmaceutical product comprising a container containing a diphosphonate in solution said diphosphonate selected from the group consisting of pamidronate, zoledronate, chlodronate, etidronate, alendronate and tiludronate wherein the solution:
- (a) has a pH of between 5 and 8;
- and
- (b) is free of organic acid buffer and polyethylene glycol
- and wherein the container consists of at least one component manufactured from glass having at least a surface in contact with the solution, at least one said surface having been pre-treated so as to protect against the leaching of impurities from the glass by the solution.
A pharmaceutical product according to any one of the preceding claims wherein the diphosphonate is pamidronate.
A pharmaceutical product according to any one of the preceding claims wherein the diphosphonate is zoledronate.
A pharmaceutical product according to any one of the preceding claims wherein the pH of the solution is approximately 6.5.
A pharmaceutical product comprising a container containing a diphosphonate in solution, wherein the solution:
- (a) has a pH of approximately 6.5;
- and
- (b) is free of organic acid buffer and polyethylene glycol
- and wherein the container consists of at least one component manufactured from glass having at least a surface in contact with the solution, at least one said surface having been pretreated so as to protect against the leaching of impurities from the glass by the solution.
A pharmaceutical product comprising a container containing a diphosphonate in solution, wherein the solution:
- (a) has a pH of between 5 and 8;
- and
- (b) is free of organic acid buffer and polyethylene glycol
- and wherein the container consists of at least one component manufactured from a non-glass material.
A pharmaceutical product according to any one of the preceding claims wherein the container further comprises an elastomeric stopper.
A pharmaceutical product according to any one of the preceding claims wherein the solution further comprises mannitol.
A pharmaceutical product according to any one of the preceding claims wherein the solution further comprises sodium hydroxide.
A pharmaceutical product according to any one of the preceding claims wherein the solution further comprises phosphoric acid.
A method of preparing a pharmaceutical product comprising the steps of:
- (a) preparing a suspension of pamodronic acid in water;
- (b) adding sodium hydroxide solution to the suspension to obtain a second solution;
- (c) adjusting the pH of the second solution to between 5 and 8;
- and
- (d) transferring the second solution to a container.
A pharmaceutical product substantially as described herein with reference to any one of the examples 2 to 5.
A method of preparing pharmaceutical product substantially as described herein with reference to any one of the examples.
Dependencies are inferred from the claim text.